RACIAL AND GENDER DISPARITIES, AND IMPACT OF ANTIFIBROTIC THEPARY ON HOSPITAL OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：0
|
作者：
Ghimire, Prabina
Gupta, Sushan
Thameem, Danish
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.1913
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3193A / 3193A
页数：1
相关论文
共 50 条
  • [41] ANTIFIBROTIC THERAPY INCREASES RISK OF PULMONARY ARTERIAL HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Scullin, D.
    Barney, J.
    CHEST, 2020, 157 (06) : 157A - 157A
  • [42] OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY HYPERTENSION
    Collins, Ashley
    King, Christopher
    Shlobin, Oksana
    Nathan, Steven
    CHEST, 2020, 158 (04) : 1071A - 1072A
  • [43] Treatments And Outcomes Of Idiopathic Pulmonary Fibrosis In A Medicare Population Prior To Approval Of Antifibrotic Therapies
    Mooney, J.
    Chang, E.
    Lalla, D.
    Papoyan, E.
    Raimundo, K.
    Reddy, S. R.
    Stauffer, J. L.
    Yan, J. T.
    Broder, M. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
    Toby M. Maher
    Mary E. Strek
    Respiratory Research, 20
  • [45] Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
    Sugino, Keishi
    Ono, Hirotaka
    Watanabe, Natsumi
    Ando, Masahiro
    Tsuboi, Eiyasu
    Homma, Sakae
    Kishi, Kazuma
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [46] Comorbidities influence in idiopathic pulmonary fibrosis antifibrotic treatments
    Nieto Barbero, Ma Asuncion
    Javier Gonzalez-Gamiz, Francisco
    Jesus Rodriguez-Nieto, Ma
    Sanchez, Susana
    Gaudo, Javier
    Valenzuela, Claudia
    Lopez-Muniz, Belen
    Gomez-Carrera, Luis
    Laporta, Rosalia
    Casanova, Alvaro
    Teresa Rio, Maria
    Neumomadrid, Refipimad
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [47] Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
    Keishi Sugino
    Hirotaka Ono
    Natsumi Watanabe
    Masahiro Ando
    Eiyasu Tsuboi
    Sakae Homma
    Kazuma Kishi
    BMC Pulmonary Medicine, 21
  • [48] Pattern of Utilization for Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
    Sedarati, K.
    Gordon, J. A.
    Graham, W. B.
    Sridhar, S.
    Rawal, N.
    Mohajer, K.
    Knowles, N.
    Wei, K.
    Patino, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] EFFICACY AND SAFETY OF ANTIFIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS
    Nunez-Garcia, L.
    Valenzuela, C.
    Alonso, T.
    Vicente, E. F.
    Ancochea, J.
    Castaneda, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 759 - 760
  • [50] Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Sangaralingham, Lindsey R.
    Yao, Xiaoxi
    Sanghavi, Darshak
    Shah, Nilay D.
    Limper, Andrew H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (02) : 168 - 174
12345